GlassScriptPhysician profile
Robert P Panvini
NPI 1346313210
$9,446.26
in general payments reported to CMS, 2019-2025
39 companies · $56.47 in 2025
The $56.47 reported for 2025 was less than what a typical Pediatric Urology provider received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,814 · 2020: $812 · 2021: $1,653 · 2022: $1,375 · 2023: $2,644 · 2024: $1,092 · 2025: $56.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,301 · Consulting Fee: $788 · Travel and Lodging: $404 · Education: $299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,301.26 |
| Consulting Fee | $788.00 |
| Travel and Lodging | $404.18 |
| Education | $298.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $2,079.97 | 2019-2024 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $1,413.53 | 2019-2024 | Erleada, Balversa, Akeega |
| Bayer Healthcare Pharmaceuticals INC. | $1,145.82 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $643.40 | 2023-2024 | Gemtesa, Orgovyx |
| Amgen INC. | $512.00 | 2019-2023 | Xgeva |
| Teleflex LLC | $434.23 | 2022-2023 | Urolift |
| Antares Pharma, INC. | $306.60 | 2019-2023 | Tlando, Xyosted, Nocdurna |
| Dendreon Pharmaceuticals LLC | $291.01 | 2019-2023 | Provenge |
| Coloplast Corp | $285.47 | 2019-2025 | Speedicath |
| Urovant Sciences INC | $274.48 | 2022 | |
| Abbvie INC. | $257.90 | 2019-2024 | |
| 180 Medical, INC. | $256.16 | 2019-2022 | |
| Pfizer INC. | $246.68 | 2019-2024 | |
| Allergan, INC. | $160.62 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $112.56 | 2020-2024 | Lynparza |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $108.57 | 2019-2020 | |
| Accord Healthcare, INC. | $101.53 | 2022-2024 | |
| Endo Pharmaceuticals INC. | $83.74 | 2022-2023 | Xiaflex, Aveed |
| Tolmar Pharmaceuticals, INC. | $76.63 | 2019-2021 | |
| Myriad Genetic Laboratories, INC. | $72.19 | 2020-2023 | Prolaris |
| Progenics Pharmaceuticals, INC. | $69.20 | 2022-2023 | Pylarify |
| Immunitybio, INC. | $63.34 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $41.43 | 2022 | |
| Tolmar, INC. | $41.09 | 2023 | |
| Dentsply Ih INC. | $39.21 | 2019-2020 | |
| Ethicon US, LLC | $38.42 | 2023 | Vistaseal |
| Photocure INC | $33.56 | 2019-2020 | |
| Clarus Therapeutics INC. | $32.63 | 2021 | |
| Myovant Sciences INC. | $27.40 | 2021 | |
| Foundation Medicine, INC. | $24.37 | 2020 | |
| Assertio Therapeutics, INC. | $23.54 | 2020 | |
| Neotract INC. | $21.56 | 2020 | |
| Therapeuticsmd, INC. | $20.96 | 2021 | |
| Urogen Pharma, INC. | $20.85 | 2021 | |
| Procept Biorobotics Corporation | $19.25 | 2019 | |
| Emd Serono, INC. | $18.90 | 2021 | |
| Hollister Incorporated | $18.66 | 2022 | |
| Axonics, INC. | $17.01 | 2021 | |
| Blue Earth Diagnostics | $11.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Panvini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.